Drug Bites Man

October, 9, 2017 | 4 Comments

Comments

  1. It will have escaped no ones notice, even un-doggy types, that this story bears a remarkable similarity to that of Paxil and Paroxetine.

    From the discussions between the FDA and Pfizer as to what to put on the labelling ie death – went to and fro, whilst K9s were suffering, to the Dear Doctor letter sent out, to an eventual compromise on choice of language and generally a worked-out compromise between the leaders

    The WSJ got the doggy owners hackles up, the fur around their backs upright and they gave a slow growl of displeasure to may be realise why their pets were dead or indecently treated ..

    http://zenequus.blogspot.co.uk/2009/07/dr-andrew-jones-dvm-speaks.html

    A very popular NSAID is Rimadyl. It has resulted in all the above reported side-effects. In fact it was first created as a human anti-inflammatory product, but due to the incidence of serious liver side effects in clinical trials, it was pulled from the human market. The drug company, Pfizer, then brought it back to life in the pet industry. It has caused a huge number of serious side effects in pets, including death. Here is what Chris Adams of the Wall Street Journal had to say… “Since Rimadyl’s 1997 launch, the FDA has received reports of about 1,000 dogs that died or were put to sleep and 7,000 more that had bad reactions after taking the drug, records and official estimates indicate. The FDA says such events are significantly underreported.”
    Chris Adams, Wall Street Journal

    I, a knowledgeable veterinarian with over 15 years of experience, contributed to my pet’s death.

    I came to question exactly why I believed in utilizing only “conventional” veterinary medicine to heal pets. I questioned all the “scholarly information” that I had been taught in veterinary school. I did some deep soul searching… WHY did this happen?

    It happened because I didn’t question modern veterinary medicine, and I gave Hoochie harmful medication. I fed him “veterinary approved” food, and I injected his body yearly with cancer inducing vaccines. WHO was to blame?

    I gave him the medication, the vaccines and the carcinogenic food. Yes, my profession, the large drug companies, and the food companies played a role. But, I should have known better.

    HOW can I prevent this from happening again to another pet? From the anger, the pain and the despair, a switch happened. I began to read, to research, to discuss with other colleagues the pitfalls of the current state of modern veterinary practice, and I wrote a book. I spent thousands of hours exploring ways for pet owners to administer first aid, improve behavior problems, and even treat illnesses using readily available household products. I began using my “newer” style of medicine in my practice, and my patients benefited tremendously from this research.

    July 23, 2009
    Dr. Andrew Jones, DVM

    Wouldn’t it be wonderful if our gps/psychiatrists took in what Dr. Andrew Jones said in his last paragraph and with a spot of humility took a bit of a stand instead of being lame ducks ..

    “But, I should have known better” ..

  2. We’re living through an epidemic of social disconnection, in which ever-growing numbers of people live alone and/or have no close confidantes in their daily lives. Vets encounter more and more people whose attachment to their dogs, and grief at their passing, seems more like what you’d feel for a spouse or a child than a pet. At the same time animal medicine has all manner of new procedures to offer – hip operations, MRI’s, chemo – that run the risk of bankrupting the human and causing unacceptable suffering to the dog. It’s always been a stressful job, it seems, but these days the emotional toll can be too much for many vets.

    But when one-fifth of dog owners would spend “whatever it took” to buy an aging dog an extra year or two of life, and 53% find their dog’s companionship more satisfying than that of their family, there are also millions to be made.

    On the surface, an arthritis pill seems like a less drastic choice than surgery. But if things do go wrong, dogs can’t tell us where it hurts, much less make their own choices. You don’t have to satisfy the patient, just convince the guardian s/he is doing the right thing. From a business standpoint, that makes them ideal patients. Not too different from troubled children, or adults with “severe mental illness”, those other tempting targets who can be medicated on someone else’s say-so …

    Meanwhile the idea of dogs as ideal companions is promoted by everyone from pet shops to therapists. Get a dog! They’ll relieve that gnawing loneliness, help you get some exercise, even serve as an ice-breaker who can help you meet people. So a lot of people get dogs who are unable to care for them—including those who live in apartments and are gone most of the day. Inevitably dogs grow “anxious” and “depressed” with “behavior disorders” of chewing, scratching and barking. If you’ve got the money and are willing to spend it, there is actual doggy daycare in many cities. If not, there’s doggy Prozac as described in last week’s column.

  3. Forget Sick as a dog…..Sick as a parrot……. Sick as a pig……..Big Pharma is sicker !!!!!! Or should that be slicker 🙁

  4. Drug bites man … in the eye ..

    Eye for Pharma is their own playground.

    I put myself down as Pharmaceutical Researcher to gain access and over the last few month I am bombarded with emails from E f P.

    Content is (still) king struck me as worth worth repeating ..

    http://www.eyeforpharma.com/marketing/conference-agenda.php?utm_campaign=4817-11OCT17-WK3-TA&utm_medium=email&utm_source=Eloqua&elqTrackId=d57950d18f7e4e2f92c2a44bbb6d6123&elq=c0bb61a7af31492e9704c52927c70c80&elqaid=31462&elqat=1&elqCampaignId=15346

    Content is (still) king

    How can content produced by pharma companies be relevant when competing with other information hubs
    Invest in tailored, useful and educational material to support your brand positioning for both physicians and patients
    Understand how change in mind-set from pharma to publisher can unlock the potential to pharma becoming a core information hub

    Paul DixeyGlobal Multichannel Marketing Director- Vaccines Franchise Partner GSK

    A bite from the Institute of Directors about the ‘sport’ ..

    http://www.pharmafile.com/news/515343/gsk-ranked-bottom-good-governance-report

    Ken Olisa, Deputy Chair of the Institute of Directors, said of the report: “I would argue that business is a form of sport. And as with any sport, championship requires a comprehensive understanding of the human, the equipment, the arena and of course the rules. An obsession with only one of those elements – for example, the rules – won’t win medals. And equally, conformity in which all of the participants are required to act in identical ways is antithetical to competition.”

    Nice one!

    Content is (still) king ..

Leave a Reply